ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

VYZULTA
Glaucoma
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

VYZULTA Rx

Generic Name and Formulations:
Latanoprostene bunod 0.024%; oph soln; contains benzalkonium chloride.

Company:
Bausch Health Companies Inc.

Therapeutic Use:

Indications for VYZULTA:

Open-angle glaucoma. Ocular hypertension.

Adult:

>16yrs: instill 1 drop in the affected eye(s) once daily in the PM.

Children:

≤16yrs: not recommended.

Warnings/Precautions:

Do not exceed recommended dose (may reduce efficacy). History of ocular inflammation: not recommended if active inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Bacterial keratitis may occur (due to multiple-dose containers). Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.

Pharmacological Class:

Prostaglandin analogue.

Interactions:

Allow at least 5mins between application of other topical oph agents.

Adverse Reactions:

Conjunctival hyperemia, eye irritation, eye pain, instillation site pain; increased ocular pigmentation (eg, iris [may be permanent], eyelid, eyelashes), other eyelash/lid changes, macular edema (including cystoid macular edema).

Generic Availability:

NO

How Supplied:

Soln—5mL

Sign Up for Free e-newsletters